CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project aims to create an advanced bioinformatics platform for personalized cancer immunotherapy. It will integrate next-generation sequencing data with clinical information to develop tools for patient-specific cancer treatments and improve the efficiency of cancer vaccine development.
Cancer treatment platforms that involve the use of the adaptive immune system have demonstrated profound tumour regressions including complete cure.
Importantly, technological advances in next-generation sequencing (NGS) allow for the first time the development of personalised cancer immunotherapies that target patient specific mutations.
However, clinical application is currently hampered by specific bottlenecks in bioinformatics, which we aim to address in this proposal.
The overall objective…
MEDIZINISCHE UNIVERSITAT INNSBRUCK
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Tuebingen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Netherlands, Utrecht
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Czechia, Brno
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
